I was so honoured and excited to speak to emerging leaders from industries across Australia as part of the American Chamber of Commerce Academy Leadership Program. I spoke about my leadership evolution, my five pillars of leadership growth, as well as my 'third space' leadership

PhD Opportunity. Join our world-leading team at Melanoma Institute Australia & @Sydney_Uni to investigate why liver metastases reduce response to life-saving #immunotherapy in #melanoma & develop new strategies to overcome it. What you’ll do: • Analyse patient immune profiles &

James Madison Dukes Shirt of the Month Get officially-licensed JMU Dukes T-shirts, long-sleeves & hoodies monthly

I am so proud of leading the #Neoadjuvant NADINA phase 3 clinical trial (with Dutch colleague Prof Blank from @NKI_nl) and with the support of my amazing colleagues at @MelanomaAus. Today, this #immunotherapy regimen (ipilimumab+nivolumab) is listed on PBS for ALL AUSSIES with

I’m honoured to be recognised as a Fellow of the American Society of Clinical Oncology (#FASCO). The American Society of Clinical Oncology (@ASCO) is the world’s leading professional organisation for oncologists, with a mission to conquer cancer through research, education, and

INNOVATE conference Naples - I love this think tank meeting! 2nd yr colleague Paolo Ascierto has hosted small but lively group of clinician researchers, clinical trialists and drug developers discuss an ALL #CANCER #NEOADJUVANT #immunotherapy approach.  It is one of my favourite

This year, I was proud to be invited to write the foreword for the #JournalOfScienceExtensionResearch. This journal is an incredible initiative of the NSW Department of Education which showcases and celebrates the amazing work of science extension high school students. It

The neoadjuvant (pre-surgery) use of combination immunotherapy as frontline treatment for high risk Stage III melanoma has been approved by the Pharmaceutical Benefits Advisory Committee (#PBAC) and will soon be listed on the #PBS and subsidised for all Australian patients.   The

The inaugural NSW Cancer Summit is being hosted by Cancer Institute NSW on 13 & 14 August. As Co-Chair of the Breakthrough in Oncology stream, I look forward to discussions around new advances in cancer diagnosis and treatment. Find out more > https://t.co/5RVdJOW12H

It was an honour to deliver the Opening Keynote Address at the Asia-Pacific Vaccine and Immunotherapy Congress (APVIC) in Brisbane this week. I spoke about Therapeutic Cancer Vaccine development and Immunotherapies - Melanoma is the ‘paradigm shifter’ in cancer drug development.

I just had the exciting opportunity to speak at the @RACSurgeons conference! My colleagues from @MelanomaAus, Alex van Akkooi and David Coker, hosted the session where I shared groundbreaking work on #neoadjuvant #immunotherapy – giving cancer drugs before surgery, which is

Important week for all of us – international #women’s day week! UN - marching forward for gender equality. Honoured to speak at many events – spoke about courage, unconscious bias, inspiration, and my 5 best pieces advice received & given to help translate action into change,

Watch recording of session here > https://t.co/P7YIxOejmt #IWD2025

Celebrating International Women’s Day - speaking to kids around Australia on being curious, science, cancer & the challenges & successes in curing #cancer. Loved the interaction! Thank you to my patient - Sandra Moore - a #melanoma survivor, who consented to an #immunotherapy

https://t.co/hHWeSZshG1 This #science is exciting! It shows the power of vision & action in an inspired team. Within 12 days of 1st dose of triple combination #immunotherapy in #glioblastoma 1) >8x more immune cells in the #GBM, 2) immune cells were newly activated & 3) PD1 drug